INS and obesity due to melanocortin 4 receptor deficiency: Reduce markers of systemic inflammation.Increased basal metabolic rate.Improved lipid profiles.Lower body fat percentage.Improved insulin sensitivity and glucose homeostasis.Reduces the risk of obesity-related conditions.Reduces risk of diabetes mellitus.